Xiang-Dong Zhou Selected Research

nordy

2/2008	Unique proteomic features induced by a potential antiglioma agent, Nordy (dl-nordihydroguaiaretic acid), in glioma cells.
3/2007	[Effect of nordy on FPR function of malignant human glioma cell line U87].
4/2006	Nordy, a synthetic lipoxygenase inhibitor, inhibits the expression of formylpeptide receptor and induces differentiation of malignant glioma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiang-Dong Zhou Research Topics

Disease

10	Neoplasms (Cancer) 09/2017 - 04/2006
6	Lung Neoplasms (Lung Cancer) 09/2017 - 07/2007
3	Glioma (Gliomas) 02/2008 - 04/2006
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2017 - 01/2009
2	Adenocarcinoma of Lung 09/2017 - 01/2011
2	Inflammation (Inflammations) 01/2017 - 11/2013
2	Neoplasm Metastasis (Metastasis) 05/2015 - 01/2009
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2014 - 04/2007
2	Hyperplasia 01/2011 - 01/2009
2	Glioblastoma (Glioblastoma Multiforme) 03/2007 - 04/2006
1	Fibrosis (Cirrhosis) 01/2021
1	Critical Illness (Critically Ill) 01/2021
1	Gallbladder Diseases (Gall Bladder Disease) 09/2014
1	Lung Injury 11/2013
1	Adenocarcinoma 01/2013
1	Leukemia 07/2012
1	Lung Diseases (Lung Disease) 01/2011
1	Carcinogenesis 01/2009
1	Lymphatic Metastasis 01/2009

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 09/2017 - 04/2006
4	Messenger RNA (mRNA)IBA 07/2012 - 03/2007
3	nordyIBA 02/2008 - 04/2006
2	bisdemethoxycurcuminIBA 09/2017 - 05/2015
2	Cisplatin (Platino)FDA LinkGeneric 09/2017 - 07/2007
2	CurcuminIBA 09/2017 - 05/2015
2	CalciumIBA 01/2014 - 03/2007
2	Pharmaceutical PreparationsIBA 01/2013 - 02/2008
2	Sirolimus (Rapamycin)FDA Link 01/2013 - 07/2007
2	Masoprocol (Actinex)FDA Link 02/2008 - 04/2006
2	N-Formylmethionine Leucyl-PhenylalanineIBA 03/2007 - 04/2006
1	Viral RNAIBA 01/2021
1	Amino Acids FDA Link 09/2017
1	NF-kappa B (NF-kB)IBA 01/2017
1	Chloroquine (Aralen)FDA LinkGeneric 10/2016
1	AcidsIBA 12/2015
1	AntioxidantsIBA 12/2015
1	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 12/2015
1	Endoplasmic Reticulum Chaperone BiPIBA 12/2015
1	CationsIBA 01/2014
1	pyrazolanthroneIBA 11/2013
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 11/2013
1	SB 203580IBA 11/2013
1	Interleukin-8 (Interleukin 8)IBA 11/2013
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 01/2013
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2013
1	MucinsIBA 07/2012
1	ImmunosorbentsIBA 07/2012
1	EnzymesIBA 07/2012
1	PlatinumIBA 01/2011
1	scutellarinIBA 01/2011
1	Matrix Metalloproteinases (MMPs)IBA 01/2009
1	Antineoplastic Agents (Antineoplastics)IBA 02/2008
1	polypeptide 1 70kD ribosomal protein S6 kinaseIBA 07/2007
1	TOR Serine-Threonine KinasesIBA 07/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2007
1	Lipoxygenase InhibitorsIBA 04/2006
1	VimentinIBA 04/2006
1	Peptides (Polypeptides)IBA 04/2006
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 04/2006

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 09/2017 - 01/2011
1	Tibetan Traditional Medicine (Traditional Tibetan Medicine) 09/2014
1	Artificial Respiration (Mechanical Ventilation) 11/2013
1	Therapeutics 01/2011